Vanguard Group Inc Humacyte, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,058,689 shares of HUMA stock, worth $24.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,058,689

Previous 4,729,594 6.96%

Holding current value

$24.5 Million

Previous $22.7 Million 21.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.11 - $9.46 $1.68 Million - $3.11 Million	329,095 Added 6.96%	5,058,689 $27.5 Million
Q2 2024 Aug 13, 2024	BUY	$2.87 - $9.1 $2.04 Million - $6.46 Million	709,913 Added 17.66%	4,729,594 $22.7 Million
Q1 2024 May 10, 2024	BUY	$2.57 - $4.84 $2.3 Million - $4.34 Million	896,415 Added 28.7%	4,019,681 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$1.99 - $3.12 $207,555 - $325,412	104,299 Added 3.45%	3,123,266 $8.87 Million
Q3 2023 Nov 14, 2023	BUY	$2.75 - $4.48 $138,410 - $225,482	50,331 Added 1.7%	3,018,967 $8.85 Million
Q2 2023 Aug 14, 2023	BUY	$2.86 - $4.97 $6,746 - $11,724	2,359 Added 0.08%	2,968,636 $8.49 Million
Q1 2023 May 15, 2023	BUY	$2.11 - $3.25 $255,339 - $393,295	121,014 Added 4.25%	2,966,277 $9.17 Million
Q4 2022 Feb 10, 2023	BUY	$2.02 - $3.62 $351,762 - $630,386	174,140 Added 6.52%	2,845,263 $6 Million
Q3 2022 Nov 14, 2022	SELL	$1.22 - $5.14 $3,516 - $14,813	-2,882 Reduced 0.11%	2,671,123 $8.71 Million
Q2 2022 Aug 12, 2022	BUY	$3.21 - $7.86 $808,871 - $1.98 Million	251,985 Added 10.4%	2,674,005 $8.58 Million
Q1 2022 May 13, 2022	BUY	$4.65 - $7.4 $5.83 Million - $9.28 Million	1,253,788 Added 107.32%	2,422,020 $17.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $6.37 Million - $10.2 Million	878,123 Added 302.69%	1,168,232 $8.47 Million
Q3 2021 Nov 12, 2021	BUY	$9.21 - $16.99 $2.67 Million - $4.93 Million	290,109 New	290,109 $3.37 Million

Others Institutions Holding HUMA

# of Institutions

150

Shares Held

35.1M

Call Options Held

279K

Put Options Held

607K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $499M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Humacyte, Inc. Transaction History